Opportunity ID: 171553

General Information

Document Type:: Grants Notice
Funding Opportunity Number:: RFA-DK-12-505
Funding Opportunity Title:: Limited Competition for the Continuation of the Halt-Polycystic Kidney Disease Trials Data Coordinating Center (DCC) (U01)
Opportunity Category:: Discretionary
Opportunity Category Explanation::
Funding Instrument Type::
Category of Funding Activity:: Food and Nutrition
Category Explanation::
Expected Number of Awards::
Assistance Listings Number(s):: 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research
Cost Sharing or Matching Requirement:: No
Version:: Synopsis 1
Posted Date:: May 18, 2012
Last Updated Date::
Original Closing Date for Applications:: Jul 30, 2012
Current Closing Date for Applications:: Jul 30, 2012
Archive Date:: Aug 30, 2012
Estimated Total Program Funding:: $ 1,200,000
Award Ceiling:: $
Award Floor:: $

Eligibility

Eligible Applicants:: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility:: Other Eligible Applicants include the following:
As this FOA is a limited competition opportunity, only the institution that is the principal employer of the Program Director(s)/Principal Investigator(s) of the HALT Data Coordinating Center is eligible to apply to this FOA.

Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Additional Information

Agency Name:: National Institutes of Health
Description:: The purpose of this limited competition is to extend the
activities of the Data Coordinating Center (DCC) during the final two years
of patient follow-up of the two ongoing HALT-Polycystic Kidney Disease (PKD)
clinical trials.  The extension will insure the statistical power and
significance of the study outcomes.  The HALT-PKD Trials are comprised of two
studies (A & B) that are both fully enrolled.  HALT-PKD Study A is
evaluating the impact of renin-angiotensin-aldosterone system (RAAS) blockade
on progression of disease in 548 hypertensive PKD patients with estimated
glomerular filtration rate (GFR) > 60ml/min/1.73 m2. The primary endpoint
of the study is the percent change in total kidney volume, as measured by
magnetic resonance imaging (MRI) over time.  HALT-PKD Study B is evaluating
the impact of RAAS blockade on progression of disease in 472 hypertensive PKD
patients with estimated GFR 30-60 ml/min/1.73 m2. The primary endpoint of
Study B is a composite endpoint of time to the 50% reduction of baseline
estimated GFR, ESRD (initiation of dialysis or preemptive transplant), or death.
Link to Additional Information::
Grantor Contact Information:: If you have difficulty accessing the full announcement electronically, please contact:

Version History

Version Modification Description Updated Date
Synopsis 1

Package Status

Below are CLOSED Opportunity Package(s) no longer available for this Funding Opportunity:

Package No: 1

Assistance Listings: 93.847
Competition ID: ADOBE-FORMS-B2
Competition Title: ADOBE-FORMS-B2
Opportunity Package ID: PKG00122610
Opening Date: Jun 30, 2012
Closing Date: Jul 30, 2012
Agency Contact Information:: Grants Info
Who Can Apply:: Organization Applicants
mendatory_forms SF424 (R & R) [V1.2]
Project/Performance Site Location(s) [V1.4]
Research And Related Other Project Information [V1.3]
Research And Related Senior/Key Person Profile (Expanded) [V1.2]
PHS 398 Cover Page Supplement [V1.4]
PHS 398 Research Plan [V1.3]
PHS 398 Checklist [V1.3]
optional_forms R & R Subaward Budget Attachment(s) Form 5 YR 30 ATT [V1.2]
PHS 398 Modular Budget [V1.2]
Research & Related Budget [V1.1]
PHS Cover Letter [V1.2]

Packages

Assistance Listings Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions Who Can Apply:
93.847 ADOBE-FORMS-B2 ADOBE-FORMS-B2 PKG00122610 Jun 30, 2012 Jul 30, 2012 View Grants Info Organization Applicants